1
To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames
Condition(s):Lymphoma LeukemiaLast Updated:June 5, 2019Unknown status
Doxorubicin Hydrochloride: 2414 Clinical Trials, Page 1 of 242
Hide Studies Not Open or Pending
2
A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer.
Condition(s):Ovarian Cancer RecurrentLast Updated:November 20, 2019Completed
3
A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer
Condition(s):HER-2 Positive Breast Cancer; Malignant Neoplasm of BreastLast Updated:February 2, 2016Terminated
4
Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer
Condition(s):Ovarian CancerLast Updated:June 5, 2017Completed
5
Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients
Condition(s):Breast Cancer; Ovarian CancerLast Updated:March 10, 2022Recruiting
6
CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER
Condition(s):Breast CancerLast Updated:February 12, 2021Active, not recruiting
7
Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer
Condition(s):Breast CancerLast Updated:May 8, 2019Completed
8
A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection
Condition(s):BioequivalenceLast Updated:July 8, 2020Completed
9
Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo
Condition(s):Advanced Malignant TumorsLast Updated:April 29, 2022Recruiting
10
Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection
Condition(s):Ovarian Epithelial Cancer RecurrentLast Updated:September 23, 2016Completed